Skip to main content

Advertisement

SpringerLink
Log in

Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors

  • Preclinical Study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Cancer-related fatigue and pain after surgery are the most frequent and most incapacitating cancer-related symptoms after breast cancer treatment. Genetic influence of cancer-related fatigue and pain has not been previously investigated. Our aim was to examine the influence of catechol-O-methyltransferase (COMT) Val158Met genotypes on cancer-related fatigue, post-mastectomy pain, and pressure pain hypersensitivity in breast cancer survivors. One-hundred and twenty-eight (n = 128) breast cancer survivors who were treated with radiotherapy and chemotherapy participated in this study. After amplifying Val158Met polymorphisms by polymerase chain reaction, COMT genotype was divided into Val/Val, valine/methionine (Val/Met), or Met/Met. The Piper fatigue scale (PFS) was used to assess cancer-related fatigue. Neck and shoulder/axillary pain intensity was assessed with a numerical pain rate scale (0–10). Finally, pressure pain thresholds (PPT) were assessed bilaterally over the C5–C6 zygapophyseal joints, deltoid muscles, second metacarpal, and tibialis anterior muscles. Breast cancer survivors carrying the Met/Met genotype reported higher levels of fatigue (all subscales, P < 0.001), higher neck pain intensity, and lower PPT over C5–C6 joints and deltoid muscles (all, P < 0.001) relative to those with Val/Met or Val/Val genotypes. The results suggest that breast cancer survivors carrying the Met/Met genotype exhibit higher fatigue, neck pain, and pressure pain hypersensitivity over the neck and shoulder area. This study is important because it strives to understand the factors that predispose some breast cancer survivors to more cancer-related fatigue and increased pain sensitivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mannisto P, Kaakkola S (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593–628

    PubMed  CAS  Google Scholar 

  2. Strous RD, Bark N, Woerner M, Lachman HM (1997) Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41:493–495

    Article  PubMed  CAS  Google Scholar 

  3. Syvanen AC, Tilgmann C, Rinne J, Ulmanen I (1997) Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of SCOMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics 7:65–71

    Article  PubMed  CAS  Google Scholar 

  4. Mao C, Wang XW, Qiu LX, Liao R, Ding H, Chen Q (2010) Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. Breast Cancer Res Treat 121:719–725

    Article  PubMed  CAS  Google Scholar 

  5. Ding H, Fu Y, Chen W, Wang Z (2010) COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies. Breast Cancer Res Treat 123:265–270

    Article  PubMed  CAS  Google Scholar 

  6. Nagel IE, Chicherio C, Li SC, Von Oertzen T, Sander T, Villringer A, Heekeren HR, Bäckman L, Lindenberger U (2008) Human aging magnifies genetic effects on executive functioning and working memory. Front Hum Neurosci 2:1

    Article  PubMed  Google Scholar 

  7. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) Val158 met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243

    Article  PubMed  CAS  Google Scholar 

  8. Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B, Mott LA (2003) The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12:612–619

    Article  PubMed  Google Scholar 

  9. Small BJ, Rawson KS, Walsh E, Jim HS, Hughes TF, Iser L, Andrykowski MA, Jacobsen PB (2011) Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer 117:1369–1376

    Article  PubMed  CAS  Google Scholar 

  10. Jim HSL, Donovan KA, Small BJ, Andrykowski MA, Munster PN, Jacobsen PB (2009) Cognitive functioning in breast cancer survivors: a controlled comparison. Cancer 115:1776–1783

    Article  PubMed  Google Scholar 

  11. Curt GA, Breitbart W, Cella D, Groopman JE, Horning SJ, Itri LM, Johnson DH, Miaskowski C, Scherr SL, Portenoy RK, Vogelzang NJ (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5:353–360

    Article  PubMed  CAS  Google Scholar 

  12. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J (2004) Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 32:40–50

    Article  PubMed  Google Scholar 

  13. Lauridsen MC, Overgaard M, Overgaard J, Hessov IB, Cristiansen P (2008) Shoulder disability and late symptoms following surgery for early breast cancer. Acta Oncol 47:569–575

    Article  PubMed  Google Scholar 

  14. Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H (2009) Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302:1985–1992

    Article  PubMed  Google Scholar 

  15. Andrykowski MA, Curran SL, Carpenter JS, Studts JL, Cunningham L, McGrath PC, Sloan DA, Kenady DE (1999) Rheumatoid symptoms following breast cancer treatment: a controlled comparison. J Pain Symptom Manag 18:85–94

    Article  CAS  Google Scholar 

  16. Gottrup H, Andersen J, Arendt-Nielsen L, Jensen T (2000) Psychophysical examination in patients with post-mastectomy pain. Pain 87:275–284

    Article  PubMed  CAS  Google Scholar 

  17. Vilholm OJ, Cold S, Rasmussen L, Sindrup SH (2009) Sensory function and pain in a population of patients treated for breast cancer. Acta Anaesthesiol Scand 53:800–806

    Article  PubMed  CAS  Google Scholar 

  18. Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-Las-Peñas C, Del-Moral-Ávila R, Arendt-Nielsen L, Arroyo-Morales M (2010) Myofascial trigger points in neck and shoulder muscles and widespread pressure pain hyper-sensitivity in patients with post-mastectomy pain: evidence of peripheral and central sensitization. Clin J Pain 26:798–806

    Article  PubMed  Google Scholar 

  19. Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-Las-Peñas C, Del-Moral-Ávila R, Menjón-Beltrán S, Arroyo-Morales M (2011) Widespread mechanical pain hyper-sensitivity as a sign of central sensitization after breast cancer surgery: comparison between mastectomy and lumpectomy. Pain Med 12:72–78

    Article  PubMed  Google Scholar 

  20. Andresen KG, Kehlet H (2010) Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. doi:10.1016/j.jpain.2010.12.005

  21. Barsevick AM, Cleeland CS, Manning DC, O’Mara AM, Reeve BB, Scott JA, Sloan JA (2010) ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes). ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manag 39:1086–1099

    Article  Google Scholar 

  22. Giacalone A, Polesel J, De Paoli A, Colussi AM, Sartor I, Talamini R, Tirelli U (2010) Assessing cancer-related fatigue: the psychometric properties of the Revised Piper Fatigue Scale in Italian cancer inpatients. Support Care Cancer 18:1191–1197

    Article  PubMed  Google Scholar 

  23. Bijur P, Silveer W, Gallagher JE (2001) Reliability of the visual analogue scale for measurement of acute pain. Acad Emerg Med 8:1153–1157

    Article  PubMed  CAS  Google Scholar 

  24. Vanderweeen L, Oostendorp RB, Vaes P, Duquet W (1996) Pressure algometry in manual therapy. Man Ther 1:258–265

    Article  PubMed  Google Scholar 

  25. Chesterson LS, Sim J, Wright CC, Foster NE (2007) Inter-rater reliability of algometry in measuring pressure pain thresholds in healthy humans, using multiple raters. Clin J Pain 23:760–766

    Article  Google Scholar 

  26. Holm S (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6:65–70

    Google Scholar 

  27. Park JW, Lee KS, Kim JS, Kim YI, Shin HE (2007) Genetic contribution of catechol-O-methyltransferase polymorphism in patients with migraine without aura. J Clin Neurol 3:24–30

    Article  PubMed  Google Scholar 

  28. García-Fructuoso FJ, Lao-Villadóniga JI, Beyer K, Santos C (2006) Relationship between catechol-O-methyltransferase genotypes and fibromyalgia’s severity. Rheumatol Clin 2:168–172

    Google Scholar 

  29. Khasar SG, Green PG, Miao FJ, Levine JD (2003) Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat. Eur J Neurosci 17:909–915

    Article  PubMed  Google Scholar 

  30. Nackley AG, Tan KT, Fecho K, Flood P, Diatchenko L, Maixner W (2007) Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both b2- and b3-adrenergic receptors. Pain 128:199–208

    Article  PubMed  CAS  Google Scholar 

  31. Diatchenko L, Slade G, Nackley AGI, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, Max MB, Makarov SS, Maixner W (2005) Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14:135–143

    Article  PubMed  CAS  Google Scholar 

  32. Rakvag TT, Klepstad P, Baar C et al (2005) The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients. Pain 116:73–78

    Article  PubMed  CAS  Google Scholar 

  33. Ross JR, Riley J, Taegetmeyer AB, Sato H, Gretton S, du Bois RM, Welsh KI (2008) Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer 112:1390–1403

    Article  PubMed  CAS  Google Scholar 

  34. Kurzrock R (2001) The role of cytokines in cancer-related fatigue. Cancer 92:S1684–S1688

    Article  Google Scholar 

  35. Collado-Hidalgo A, Bower JE, Ganz PA, Cole S, Irwin M (2006) Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 12:2759–2766

    Article  PubMed  CAS  Google Scholar 

  36. Maier SF, Watkins L (2003) Immune-to-central nervous system communication and its role in modulating pain and cognition: implications for cancer and cancer treatment. Brain Behav Immun 17(suppl 1):S125–S131

    Article  PubMed  CAS  Google Scholar 

  37. Bower JE (2007) Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 21:863–871

    Article  PubMed  CAS  Google Scholar 

  38. Cantarero-Villanueva I, Fernández-Lao C, Fernández-de-las-Peñas C, Díaz-Rodríguez L, Sanchez-Cantalejo E, Arroyo-Morales M (2011) Associations among musculoskeletal impairments, depression, body image and fatigue in breast cancer survivors within the first year after treatment. Eur J Cancer Care. doi:10.1111/j.1365-2354.2011.01245.x

  39. Hamburg MA, Collins FS (2010) The path to personalized medicine. N Engl J Med 363:301–304

    Article  PubMed  CAS  Google Scholar 

  40. Reyes-Gibby CC, Wu X, Spitz M, Kurzrock R, Fisch M, Bruera E, Shete S (2008) Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 9:777–785

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The study received some funds from the Fundación Sánchez Ibarra 2011, Spain.

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avenida de Atenas s/n, Alcorcón, 28922, Madrid, Spain

    César Fernández-de-las-Peñas

  2. Esthesiology Laboratory of Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain

    César Fernández-de-las-Peñas

  3. Department of Physical Therapy, Health Sciences Faculty, Universidad de Granada, Granada, Spain

    Carolina Fernández-Lao, Irene Cantarero-Villanueva & Manuel Arroyo-Morales

  4. Department of Anatomy, Universidad Rey Juan Carlos, Madrid, Spain

    Silvia Ambite-Quesada & Inés Rivas-Martínez

  5. Radiotherapy Breast Oncology Unit, University Hospital Virgen de las Nieves, Granada, Spain

    Rosario del Moral-Avila

Authors
  1. César Fernández-de-las-Peñas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolina Fernández-Lao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irene Cantarero-Villanueva
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvia Ambite-Quesada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Inés Rivas-Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rosario del Moral-Avila
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Manuel Arroyo-Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to César Fernández-de-las-Peñas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fernández-de-las-Peñas, C., Fernández-Lao, C., Cantarero-Villanueva, I. et al. Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors. Breast Cancer Res Treat 133, 405–412 (2012). https://doi.org/10.1007/s10549-011-1757-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-011-1757-y

Keywords

Search

Navigation